IP Library Assignment 059855/0333
Patent Assignment
Reel/Frame 059855/0333

Name and Address Change

Recorded: 2022-05-04 Pages: 12
Assignor
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Properties (21)
Method of Inhibiting Sensory Neuron Specific Sodium Channel
Application: 13/895,089 →
Publication: US 2013/0303535
Tablet Quickly Disintegrating in the Oral Cavity and Method for Producing the Same
Application: 14/806,296 →
Publication: US 2015/0320688
Novel Anticancer Agent
Application: 15/317,471 →
Publication: US 2017/0121299
Production Method for Nerve Tissue
Application: 15/521,334 →
Publication: US 2017/0313976
Production Method for Retinal Tissue
Application: 15/521,387 →
Publication: US 2017/0313981
Method for Producing Retinal Pigment Epithelial Cells
Application: 15/757,202 →
Publication: US 2018/0258388
Method for Producing Retinal Tissue
Application: 15/758,255 →
Publication: US 2018/0245039
Novel Anticancer Agent
Application: 15/987,525 →
Publication: US 2018/0265489
Method for Producing Retinal Tissue
Application: 16/095,339 →
Publication: US 2019/0127690
Transplantation Medium
Application: 16/313,694 →
Publication: US 2020/0009196
Novel Anticancer Agent
Application: 16/455,707 →
Publication: US 2019/0322636
Method for Producing Retinal Pigment Epithelial Cells
Application: 16/491,746 →
Publication: US 2020/0010801
Diagnostic Drug and Diagnostic Method for Alzheimer's Disease
Application: 16/544,383 →
Publication: US 2019/0369124
Method for Maturation of Retinal Tissue Containing Continuous Epithelium
Application: 16/632,362 →
Publication: US 2020/0208103
Method for Producing Retinal Tissues
Application: 16/647,441 →
Publication: US 2021/0154370
Method for Amplifying Cone Photoreceptors or Rod Photoreceptors Using Dorsalization Signal Transmitter or Ventralization Signal Transmitter
Application: 16/647,454 →
Publication: US 2020/0277571
Anticancer Agent
Application: 16/907,463 →
Publication: US 2020/0317630
Diagnostic Drug and Diagnostic Method for Alzheimer's Disease
Application: 17/265,805 →
Publication: US 2021/0165002
Transdermal Cancer Antigen Peptide Preparation
Application: 17/529,046 →
Publication: US 2022/0062421
Production Method for Nerve Tissue
Application: 17/559,458 →
Publication: US 2022/0112457
Production Method for Retinal Tissue
Application: 17/567,708 →
Publication: US 2022/0119764
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Aug 25, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033606/0307 →
Assignment of Assignor's Interest Dec 9, 2016
From: YOSHIMURA, YOSHINOBU; KASAI, MASAYASU; SHOJI, YOSHIMICHI; TAKEDA, SHIGEMITSU
To: KYOTO PHARMACEUTICAL INDUSTRIES, LTD.
Reel/Frame 040961/0294 →
Assignment of Assignor's Interest Mar 22, 2017
From: KYOTO PHARMACEUTICAL INDUSTRIES, LTD.
To: KYOTO PHARMACEUTICAL INDUSTRIES, LTD.; SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 041687/0759 →
Assignment of Assignor's Interest Jun 15, 2017
From: KUWAHARA, ATSUSHI; YAMASAKI, SUGURU; HIRAMINE, YASUSHI; SASAI, MIYUKI (LEGAL REPRESENTATIVE OF DECEASED INVENTOR YOSHIKI SASAI)
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; RIKEN; SUMITOMO CHEMICAL COMPANY, LIMITED
Reel/Frame 042721/0771 →
Assignment of Assignor's Interest Jun 15, 2017
From: KUWAHARA, ATSUSHI; YAMASAKI, SUGURU; HIRAMINE, YASUSHI; SASAI, MIYUKI (LEGAL REPRESENTATIVE OF DECEASED INVENTOR YOSHIKI SASAI)
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; RIKEN; SUMITOMO CHEMICAL COMPANY, LIMITED
Reel/Frame 042726/0054 →
Assignment of Assignor's Interest Mar 2, 2018
From: ANDO, SATOSHI; KURODA, TAKAO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; HEALIOS K.K.
Reel/Frame 045093/0717 →
Assignment of Assignor's Interest Mar 7, 2018
From: ANDO, SATOSHI; KURODA, TAKAO; SASAI, MIYUKI (LEGAL REPRESENTATIVE OF DECEASED INVENTOR YOSHIKI SASAI)
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; SUMITOMO CHEMICAL COMPANY, LIMITED; RIKEN
Reel/Frame 045136/0719 →
Assignment of Assignor's Interest Nov 19, 2018
From: KUWAHARA, ATSUSHI; YAMASAKI, SUGURU; SASAI, MIYUKI (LEGAL REPRESENTATIVE OF DECEASED INVENTOR YOSHIKI SASAI); TAKAHASHI, MASAYO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; RIKEN; SUMITOMO CHEMICAL COMPANY, LIMITED
Reel/Frame 047541/0658 →
Assignment of Assignor's Interest Dec 27, 2018
From: OTAGIRI, DAI; MAEDA, TADAO
To: HEALIOS K.K.; SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 047862/0110 →
Assignment of Assignor's Interest Sep 6, 2019
From: KURODA, TAKAO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; HEALIOS K.K.
Reel/Frame 050293/0466 →
Assignment of Assignor's Interest Jan 21, 2020
From: SAKAGUCHI, HIDEYA; SASAI, MIYUKI (LEGAL REPRESENTATIVE OF DECEASED INVENTOR YOSHIKI SASAI); EIRAKU, MOTOTSUGU; NUKAYA, DAIKI
To: RIKEN; SUMITOMO DAINIPPON PHARMA CO., LTD.; SUMITOMO CHEMICAL COMPANY, LIMITED
Reel/Frame 051574/0397 →
Assignment of Assignor's Interest Mar 14, 2020
From: NUKAYA, DAIKI; EIRAKU, MOTOTSUGU; KINOSE, YUIKO; ONISHI, AKISHI
To: RIKEN; SUMITOMO DAINIPPON PHARMA CO., LTD.; SUMITOMO CHEMICAL COMPANY, LIMITED
Reel/Frame 052117/0928 →
Assignment of Assignor's Interest Mar 14, 2020
From: NUKAYA, DAIKI; EIRAKU, MOTOTSUGU; KINOSE, YUIKO; ONISHI, AKISHI
To: RIKEN; SUMITOMO DAINIPPON PHARMA CO., LTD.; SUMITOMO CHEMICAL COMPANY, LIMITED
Reel/Frame 052117/0911 →
Assignment of Assignor's Interest Feb 3, 2021
From: OHNO, ATSUSHI; TERANISHI, YASUHIRO; KUSUMOTO, MASANORI; HASHIMOTO, MASAKAZU
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 055213/0570 →
Assignment of Assignor's Interest Jan 8, 2022
From: DOR, AVNER; SHANY, YARON; DOUBCHAK, ARIEL; BERMAN, AMIT
To: SAMSUNG ELECTRONICS CO., LTD.
Reel/Frame 058586/0545 →
Assignment of Assignor's Interest Mar 28, 2023
From: HEALIOS K.K.
To: HEALIOS K.K.
Reel/Frame 063325/0645 →
Assignment of Assignor's Interest Nov 27, 2023
From: SUMITOMO CHEMICAL COMPANY, LIMITED
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 065666/0629 →
Assignment of Assignor's Interest Oct 4, 2024
From: SUMITOMO CHEMICAL COMPANY, LIMITED
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 068799/0134 →
Assignment of Assignor's Interest Sep 30, 2025
From: SUMITOMO PHARMA CO., LTD.
To: RACTHERA CO., LTD.
Reel/Frame 072825/0888 →